Forecasting with the Parsimonious Method and Estimating Share Value Using the DCF ModelFollowing are income statements and balance sheets for Natural Health.Natural Health $2022$ Balance SheetIn USD millions except per share amounts$2022$Period Ended$12/31/2022$Cash and Equivalents$12,945\mathrm{.}00$Short$-$Term Investments$2,778\mathrm{.}00$Trade Receivables$27,276\mathrm{.}00$Inventories$19,090\mathrm{.}00$Deferred Tax Assets, CurrentDivestment Assets, Current$908$Prepaid Expenses and Other Current Assets$2,636\mathrm{.}00$Total Current Assets$65,633\mathrm{.}00$Property, Plant and Equipment$12,873\mathrm{.}00$Property, Plant and Equipment, Net$12,873\mathrm{.}00$Right$-$Of$-$Use Assets$17,872\mathrm{.}00$Long$-$Term Investments$21,096\mathrm{.}00$Goodwill$78,150\mathrm{.}00$Intangible Assets, Net$24,803\mathrm{.}00$Other Assets$7,848\mathrm{.}00$Total Assets$228,275\mathrm{.}00$Accounts Payable$24,980\mathrm{.}00$Debt, Current$1,778\mathrm{.}00$Operating Lease Liabilities, Current$1,678\mathrm{.}00$Divestment Liabilities, Current$228$Accrued and Other Current Liabilities$40,757\mathrm{.}00$Total Current Liabilities$69,421\mathrm{.}00$Long$-$Term Debt and Capital Lease Obligations$50,476\mathrm{.}00$Operating Lease Liabilities, Noncurrent$16,800\mathrm{.}00$Deferred Taxes, Noncurrent$4,016\mathrm{.}00$Other Noncurrent Liabilities$15,793\mathrm{.}00$Total Liabilities$156,506\mathrm{.}00$Commitments and ContingenciesCommon Stock$48,193\mathrm{.}00$Additional Paid In CapitalTreasury Stock$-31,858\mathrm{.}00$Accumulated Other Comprehensive Income$-1,264\mathrm{.}00$Retained Earnings $($Deficit$)56,398\mathrm{.}00$ESOP and Employee Related EquityTotal Equity Attributable to Parent$71,469\mathrm{.}00$Noncontrolling Interest$300$Total Equity$71,769\mathrm{.}00$Total Liabilities and Equity$228,275\mathrm{.}00$Natural Health $2022$ Income statementIn USD millions except per share amounts$2022$Period Ended$12/31/2022$Operating Revenue$321,629\mathrm{.}00$Cost of Revenue$267,965\mathrm{.}00$Gross Profit$53,664\mathrm{.}00$Restructuring and Impairment Charges$2,533\mathrm{.}00$Nonrecurring and Special Charges$5,803\mathrm{.}00$Other Operating Expenses$38,212\mathrm{.}00$Total Operating Expenses$46,548\mathrm{.}00$Operating Income$7,116\mathrm{.}00$Interest Expense$-2,287\mathrm{.}00$Interest and Investment Income$838$Restructuring and Impairment ChargesOther Income $($Expense$)169$Total Other Income $($Expense$)-1,280\mathrm{.}00$Income Before Income Taxes$5,836\mathrm{.}00$Income Taxes$1,509\mathrm{.}00$Discontinued OperationsConsolidated Net Income $($Loss$)4,327\mathrm{.}00$Non$-$controlling Interest$-16$Other Adjustments to IncomeNet Income $($Loss$)$ Attributable to Common Shareholders, Basic$4,311\mathrm{.}00$Net Income $($Loss$)$ Attributable to Common Shareholders, Diluted$4,311\mathrm{.}00$Basic Earnings Per Share$3\mathrm{.}29$Diluted Earnings Per Share$3\mathrm{.}26$Basic Shares Outstanding$1,312\mathrm{.}00$Diluted Shares Outstanding$1,323\mathrm{.}00$Terminal period growth rate$2\%$Forecast Growth$3\%$WACC$5\mathrm{.}6\%$Tax rate$\mathrm{.}26\%$Common shares outstanding$1,284,111,667$ GROWTHHISTORICAL DATAFORECAST $3\%$FORECAST $3\%$FORECAST $3\%2\%$SALES$321,629$answeransweransweranswerNOPAT answeransweransweransweranswerNOA answeransweransweransweranswerIncrease in NOAansweransweransweranswerFCFF $($NOPAT $-$ Increase in NOA$)$answeransweransweranswerDiscount factorCum Present Value of Horizon FCFFanswerPresent Value of TerminalanswerFirm ValueanswerLess NNOanswerEquity ValueanswerValue per share $($Equity value$/$out$.$ shares$)$answer